Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 13 Issue: 7
Author(s): Maria N. Modica
Affiliation:
Export Options
About this article
Cite this article as:
Modica N. Maria, Meet Our Editorial Board Member, Medicinal Chemistry 2017; 13 (7) . https://dx.doi.org/10.2174/157340641307171018121731
DOI https://dx.doi.org/10.2174/157340641307171018121731 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progranulin Regulates Inflammation and Tumor
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Biology and Medicinal Chemistry of Epothilones
Current Medicinal Chemistry - Anti-Cancer Agents Involvement of the Blood-Brain Barrier in Metabolic Regulation
CNS & Neurological Disorders - Drug Targets Feasibility Study Evaluating Pentravan® for the Intravaginal Administration of Active Pharmaceutical Ingredients to Reduce Pelvic Pain Related to Endometriosis
Drug Delivery Letters The Accomplices of NF-κB Lead to Radioresistance
Current Protein & Peptide Science Targeted Drug Delivery to Cancer Stem Cells through Nanotechnological Approaches
Current Stem Cell Research & Therapy Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design Physiological Roles of Asialoglycoprotein Receptors (ASGPRs) Variants and Recent Advances in Hepatic-Targeted Delivery of Therapeutic Molecules Via ASGPRs
Protein & Peptide Letters Targeting Interleukin-1β for Pain
CNS & Neurological Disorders - Drug Targets Pharmacogenetics: Recent Past Points to the Path Ahead
Current Pharmacogenomics Gender Differences in Metabolic Syndrome – A Key Research Issue
Endocrine, Metabolic & Immune Disorders - Drug Targets Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation
Current Pharmaceutical Design Pharmacological Inhibition of Voltage-gated Ca<sup>2+</sup> Channels for Chronic Pain Relief
Current Neuropharmacology Population Pharmacokinetics and Pharmacodynamics of Albinterferon Alfa-2b in Patients Treated for Hepatitis C Virus Genotype 2/3
Anti-Infective Agents Targeting the BRCA1/2 Tumor Suppressors
Current Drug Targets Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus- Host Disease After Allogeneic Hematopoietic Cell Transplantation
Current Stem Cell Research & Therapy Healing or Not Healing
Current Pharmaceutical Biotechnology ADP-Ribosyltransferases and Poly ADP-Ribosylation
Current Protein & Peptide Science BCG Vaccine, A Ray of Hope in Treating Severe Acute Respiratory Syndrome (SARS)
Infectious Disorders - Drug Targets Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways
Current Signal Transduction Therapy